《2012北美绝经学会激素治疗立场声明》内容预览
Objective: This position statement aimed to update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2010 regarding recommendations for hormone therapy (HT) for postmenopausal women. This updated position statement further distinguishes the emerging differences in the therapeutic benefit-risk ratio between estrogen therapy (ET) and combined estrogen-progestogen therapy (EPT) at various ages and time intervals since menopause onset.
《2012北美绝经学会激素治疗立场声明》完整版下载地址:
http://ziyuan.iiyi.com/source/down/1448613.html